Rating History for Teva Pharma (TEVA) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for TEVA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/28/2026 David Amsellem Maintain Overweight
(N/A)		 44.00
(42.00)		  
 		   Details